This week, Marianna is sitting down with John Faragon to talk about the recently published five year data on treatment naïve subjects initiating therapy with bictegravir/tenofovir alafenamide/emtricitabine (that's a mouthful!) or BFTAF. Learn all about BFTAF and why it matters for you as an HIV care provider.  --Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)--Want to chat? Email us at [email protected] with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

Ver todos los episodios